These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9440720)
1. Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance. Terol MJ; López-Guillermo A; Bosch F; Villamor N; Cid MC; Rozman C; Campo E; Montserrat E J Clin Oncol; 1998 Jan; 16(1):35-40. PubMed ID: 9440720 [TBL] [Abstract][Full Text] [Related]
2. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome. Terol MJ; Tormo M; Martinez-Climent JA; Marugan I; Benet I; Ferrandez A; Teruel A; Ferrer R; García-Conde J Ann Oncol; 2003 Mar; 14(3):467-74. PubMed ID: 12598355 [TBL] [Abstract][Full Text] [Related]
3. Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features. Terol MJ; López-Guillermo A; Bosch F; Villamor N; Cid MC; Campo E; Montserrat E J Clin Oncol; 1999 Jun; 17(6):1869-75. PubMed ID: 10561227 [TBL] [Abstract][Full Text] [Related]
4. Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin's lymphomas, including lethal midline granuloma. Harabuchi Y; Kataura A; Imai K Ann Otol Rhinol Laryngol; 1996 Aug; 105(8):634-42. PubMed ID: 8712635 [TBL] [Abstract][Full Text] [Related]
5. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Horst E; Meijer CJ; Radaszkiewicz T; Ossekoppele GJ; Van Krieken JH; Pals ST Leukemia; 1990 Aug; 4(8):595-9. PubMed ID: 1974938 [TBL] [Abstract][Full Text] [Related]
6. Expression of adhesion molecules LFA-1, ICAM-1, CD44, and L-selectin in childhood non-Hodgkin lymphomas. Yaris N; Büyükpamukçu M; Kansu E; Canpinar H Med Pediatr Oncol; 2001 Mar; 36(3):359-64. PubMed ID: 11241437 [TBL] [Abstract][Full Text] [Related]
7. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas. Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134 [TBL] [Abstract][Full Text] [Related]
9. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma. Joensuu H; Ristamäki R; Söderström KO; Jalkanen S J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487 [TBL] [Abstract][Full Text] [Related]
11. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma]. Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038 [TBL] [Abstract][Full Text] [Related]
12. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma. Abdelrazik N; Fouda M; Zaghloul MH; Abbas D Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393 [TBL] [Abstract][Full Text] [Related]
13. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases]. Ding SL; Ko WS; Hwang WS J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. Conlan MG; Bast M; Armitage JO; Weisenburger DD J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234 [TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma. Chatzitolios A; Venizelos I; Tripsiannis G; Anastassopoulos G; Papadopoulos N Ann Hematol; 2010 Sep; 89(9):889-96. PubMed ID: 20352431 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682 [TBL] [Abstract][Full Text] [Related]
18. Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project. Ann Oncol; 1997 Oct; 8(10):973-8. PubMed ID: 9402170 [TBL] [Abstract][Full Text] [Related]
19. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A; Berg R Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605 [TBL] [Abstract][Full Text] [Related]
20. Intercellular adhesion molecule-1(ICAM-1), CD44s expression and serum level of sICAM-1 in disseminated non-Hodgkin's lymphoma: correlation with overall survival. Aboul-Enein M; El-Sayed GM; El-Maghraby S; Abd-Elatif NA; Abd Elwahab GA; Elbasmy AA J Egypt Natl Canc Inst; 2004 Dec; 16(4):244-51. PubMed ID: 16116502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]